Company intelligence / Profile preview

Lavilabor Natural Products

Miami, Florida, United Stateslavior.com ↗

Ownership: Private
Development stage: Other

Overview

Lavilabor/Lavior has developed a proprietary bio-engineered botanical extract from Inula viscosa that has been clinically proven in FDA trials to accelerate healing of chronic wounds—moving them from the inflammatory stage to healing within three weeks. Their products are FDA registered and have received international certifications. The company’s solutions are especially targeted at diabetic wound care and chronic skin conditions.

Therapeutic areas: DermatologyEndocrinologyCardiovascularOther
Modalities: Small moleculeBotanical extractBiologic
Industry: Therapeutic Medical Devices

Partnerships

American Diabetes Association ("Better Choices for Life" program)U.S. Government/Department of Defense vendor status

Beyond the preview

Go deeper on Lavilabor Natural Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lavilabor Natural Products.